MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists weaponize Patients' own cells to hunt down blood cancer
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who still have detectable cancer cells after initial treatment. Doctors collect a patient's own immune cells, modify them in a lab to better target …
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New 'Smart Bomb' drug seeks to target and destroy tough blood cancers
Disease control Recruiting nowThis early-stage study aims to find a safe and effective dose of a new targeted drug, pivekimab sunirine, when given with a standard chemotherapy regimen (FLAG-Ida). It is for adults newly diagnosed with aggressive, high-risk blood cancers like acute myeloid leukemia (AML). The n…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could removing metals from the body help fight leukemia?
Disease control Recruiting nowThis early-stage study is testing whether adding metal-detoxifying drugs to standard chemotherapy can help control acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Researchers want to see if lowering metal levels in the blood and bone marrow improves treatment res…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug combo trial aims to tame aggressive blood cancers
Disease control Recruiting nowThis study is testing whether adding a new drug called iadademstat to an existing treatment (ASTX727) works better for controlling advanced blood cancers. It will involve about 62 adults with specific aggressive forms of myeloproliferative neoplasms (MPNs) that have progressed. T…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for High-Risk blood cancer patients in transplant trial
Disease control Recruiting nowThis study is testing if adding a drug called ruxolitinib to standard treatment can make stem cell transplants safer and more effective for older adults with myelofibrosis or related blood cancers. The main goal is to prevent a dangerous complication where the donor cells attack …
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial targets tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called BGB-11417, both by itself and combined with an existing drug (azacitidine), for people with certain blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The main goals are to find a safe and effec…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new combination of two drugs, axatilimab and azacitidine, for people with advanced or hard-to-treat blood cancers. The first part of the study aims to find the safest and most effective dose. The second part will see how well the drug combination works to …
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Custom immune cells fight blood cancers after transplant
Disease control Recruiting nowThis study tests a personalized immune cell therapy for patients with blood cancers like leukemia, lymphoma, and myeloma. After receiving chemotherapy and a cord blood transplant, patients get infusions of natural killer (NK) cells—immune cells that may kill remaining cancer cell…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New drug combo aims to bridge patients to Life-Saving transplant
Disease control Recruiting nowThis trial is testing whether a combination of chemotherapy and targeted drugs can better prepare patients with advanced blood cancers for a stem cell transplant. The goal is to control the aggressive cancer enough so patients can safely receive donor stem cells, which may offer …
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Virtual chats aim to ease anxiety for seniors facing serious blood cancers
Symptom relief Recruiting nowThis study is testing whether a telehealth program helps older patients with serious blood cancers have better conversations with their doctors about future care wishes. It aims to see if these structured video calls reduce patient anxiety and distress, and help more people compl…
Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Mar 30, 2026 14:27 UTC